Financial News
Merck ends development of Covid drug it acquired from OncoImmune
April 15, 2021 at 06:46 AM EDT
Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
